Beijing, Moscow, Tehran demand from West to resuscitate Iran nuclear agreement

(MENAFN) Iran, Russia, and China have jointly called upon Western powers to halt what they describe as a cycle of escalating tensions and to reinstate the nuclear agreement originally agreed upon with Iran in 2015. The statement was issued in conjunction with ongoing discussions at the International Atomic Energy Agency's Board of Governors meeting in Vienna.

In their collective statement, shared by Iranian news agency Tasnim, Tehran, Moscow, and Beijing reaffirmed their steadfast support for the Joint Comprehensive Plan of Action (JCPOA). They criticized the United States for its unilateral withdrawal from the agreement in 2018, followed by the imposition of unilateral and unlawful sanctions under a policy of maximum pressure on Iran.

The JCPOA, a landmark accord signed by Iran, China, France, Germany, Russia, the United Kingdom, and the United States during President Barack Obama's administration, aimed to curb Iran's nuclear program in exchange for the lifting of international sanctions. However, the withdrawal of the United States led by then-President Donald Trump disrupted the agreement, prompting Iran to resume uranium enrichment and partially withdraw from its JCPOA commitments.

Despite ongoing efforts through nine rounds of talks in Vienna to revive the JCPOA, Iran, Russia, and China criticized France, Germany, the United Kingdom, and the current United States administration for what they perceive as divergent approaches that hinder progress toward restoring the agreement. The joint statement underscores a collective commitment to diplomatic negotiations aimed at reestablishing the JCPOA framework, emphasizing the importance of international cooperation and adherence to agreed-upon terms for regional stability and global non-proliferation efforts.



Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.